Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand

By /

Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing radioisotope-based cancer therapies.

Scroll to Top